Drug delivery to the inflamed intestinal mucosa – targeting technologies and human cell culture models for better therapies of IBD
-
Published:2021-08
Issue:
Volume:175
Page:113828
-
ISSN:0169-409X
-
Container-title:Advanced Drug Delivery Reviews
-
language:en
-
Short-container-title:Advanced Drug Delivery Reviews
Author:
Hartwig OlgaORCID,
Shetab Boushehri Maryam A.,
Shalaby Karim S.,
Loretz Brigitta,
Lamprecht Alf,
Lehr Claus-Michael
Subject
Pharmaceutical Science
Reference371 articles.
1. Ulcerative colitis;Ordás;Lancet.,2012
2. Crohn ’ s disease;Baumgart;Lancet.,2013
3. Third European evidence-based consensus on diagnosis and management of ulcerative colitis. Part 1: definitions, diagnosis, extra-intestinal manifestations, pregnancy, cancer surveillance, surgery, and ileo-anal pouch disorders;Magro;J. Crohns. Colitis.,2017
4. Life expectancy and health-adjusted life expectancy in people with inflammatory bowel disease;Kuenzig;Can. Med. Assoc. J.,2020
5. Review article: Remission rates achievable by current therapies for inflammatory bowel disease;Peyrin-Biroulet;Aliment. Pharmacol. Ther.,2011
Cited by
39 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献